Amarin | AMRN - Acción





Acción Cambio Fecha
AbbVie USD 5.13B 78M 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Amarin USD 164.07M 19.51M 2026-06
AstraZeneca USD 6.93B 362M 2026-06
BioCryst Pharmaceuticals USD 6.06M 71K 2026-06
GlaxoSmithKline GBP 6.16B 233M 2026-03
Halozyme Therapeutics USD 137.14M 18.33M 2026-06
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Novartis USD 6.22B 66M 2026-06